TSBX - Turnstone Biologics Corp.


0.3324
-0.008   -2.286%

Share volume: 170,375
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$0.34
-0.01
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024
Report Date 05-13-2024 08-14-2024 11-12-2024
Total revenue 0.000 0.000 0.000
Cost of revenue 0.000 0.000 0.000
Gross profit 0.000 0.000 0.000
    nan% nan%  
Operating expenses 20.691 M 22.057 M 18.368 M
Selling general and admin 4.901 M 4.327 M 3.944 M
Research and development 15.790 M 17.730 M 14.424 M
Total expenses 20.691 M 22.057 M 18.368 M
    6.60% -16.72%  
Operating income -20.691 M -22.057 M -18.368 M
Ebit -20.691 M -21.302 M -17.848 M
Pretax income -19.613 M -21.302 M -17.848 M
    8.61% -16.21%  
Income tax 16.000 K 2.000 K -816.000 K
Net income basic -19.629 M 0.000 0.000
    100.00%    
Net income -19.629 M -21.304 M -17.032 M
    -8.53% 20.05%